The Cigna Group (NYSE:CI – Get Free Report) has been assigned a consensus rating of “Buy” from the seventeen research firms that are presently covering the firm, Ratings reports. Two research analysts ...
Analysts have set 12-month price targets for Cigna Group, revealing an average target of $366.0, a high estimate of $390.00, ...
Cigna Group closed 13.60% below its 52-week high of $370.83, which the company reached on September 16th.
Hosted on MSN20d
Q4 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers StocksLet’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the ... The company added 96,000 customers to reach a total of 17.5 million. Interestingly, the stock is up 1.9% ...
Cigna Group closed 14.56% below its 52-week high of $370.83, which the company reached on September 16th.
StockNews.com upgraded shares of The Cigna Group (NYSE:CI – Free Report) from a buy rating to a strong-buy rating in a research note released on Saturday morning. CI has been the topic of several ...
Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth. See why I rate CI stock a buy at current prices.
Hosted on MSN3mon
Cigna (CI) Soars 6.3%: Is Further Upside Left in the Stock?This compares to the stock's 17.7% loss over the past ... and Cigna Healthcare segments are expected to buoy Cigna’s results and price performance. However, ongoing monitoring of broader market ...
Cigna Group (NYSE:CI) made a decisive move to bolster its leadership in Asia Pacific with the appointment of Rob Peat as CEO, effective April 2025, focusing on growth acceleration across key regions.
While Cigna has demonstrated flexibility in adapting to regulatory shifts, significant changes to PBM practices could materially impact the company’s operations and financial performance.
analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Cigna Group compared to the ...
While Cigna has demonstrated flexibility in adapting to regulatory shifts, significant changes to PBM practices could materially impact the company’s operations and financial performance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results